Financial Ratios

SAFIRE GLOBAL MEDICARE LTD.

NSE : NABSE : 524418ISIN CODE : Industry : Medical Equipment/Supplies/AccessoriesHouse : Private
BSE0.000 (0 %)
PREV CLOSE ( ) NA
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
Select year
ParticularsMar2011Mar2010Mar2008Mar2007Mar2005
Operational & Financial Ratios
   Earnings Per Share (Rs)-0.02-5.14-0.02-3.02-3.14
   CEPS(Rs)-0.02-5.14-0.021.191.06
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)-13.47-13.46-13.23-2.851.39
   Tax Rate(%)0.000.000.0029.6926.62
Margin Ratios
   Core EBITDA Margin(%)-59.69
   EBIT Margin(%)-3518.77
   Pre Tax Margin(%)-3521.61
   PAT Margin (%)-2584.09
   Cash Profit Margin (%)875.00
Performance Ratios
   ROA(%)-0.25-49.38-0.17-14.76-9.93
   ROE(%)0.000.000.000.00-85.28
   ROCE(%)0.000.000.00-60.84-34.36
   Asset Turnover(x)0.000.000.000.000.00
   Sales/Fixed Asset(x)0.000.000.000.000.00
   Working Capital/Sales(x)0.000.000.000.00-0.02
Efficiency Ratios
   Fixed Capital/Sales(x)516.62
   Receivable days6627.36
   Inventory Days0.00
   Payable days60.645895.18
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)0.000.000.000.000.00
   Price/Book(x)0.000.000.000.000.00
   Yield(%)
   EV/Net Sales(x)153.98
   EV/Core EBITDA(x)-608.56-2.01-715.09-194.65-257.98
   EV/EBIT(x)-608.56-2.01-715.09-3.92-4.38
   EV/CE(x)1.501.471.221.160.71
   M Cap / Sales0.00
Growth Ratio
   Net Sales Growth(%)-100.00-73.93
   Core EBITDA Growth(%)99.670.0072.78-19.2296.80
   EBIT Growth(%)99.670.0099.45-0.3334.66
   PAT Growth(%)99.660.0099.203.9248.21
   EPS Growth(%)99.660.0099.203.9248.21
Financial Stability Ratios
   Total Debt/Equity(x)-0.02-0.02-0.52-2.406.26
   Current Ratio(x)0.040.040.330.600.68
   Quick Ratio(x)0.040.040.060.140.31
   Interest Cover(x)-54.02-7417.20-35.27-3566.94-1238.75
   Total Debt/Mcap(x)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.